Search Results - "Siu LL"

Nasopharyngeal carcinoma: the next challenges.

Authors: Razak ARA Siu LL Liu F et al.

Source: European Journal of Cancer. Jul2010, Vol. 46 Issue 11, p1967-1978. 12p.

A phase 2 study of platinum and gemcitabine in patients with advanced salivary gland cancer: a Trial of the NCIC Clinical Trials Group.

Authors: Laurie SA Siu LL Winquist E et al.

Source: Cancer (0008543X). 1/15/2010, Vol. 116 Issue 2, p362-368. 7p.

Clinical trials in the elderly -- a concept comes of age.

Authors: Siu LL (AUTHOR)

Source: New England Journal of Medicine. 4/12/2007, Vol. 256 Issue 15, p1575-1576. 2p.

Clinical validation of a tissue-agnostic genome-wide methylome enrichment assay to monitor response to pembrolizumab.

Authors: Stutheit-Zhao EY Zhong Y Melton CA et al.

Source: NPJ precision oncology [NPJ Precis Oncol] 2026 Feb 13; Vol. 10 (1). Date of Electronic Publication: 2026 Feb 13.

Publication Type: Journal Article

Journal Info: Publisher: Springer Nature Country of Publication: England NLM ID: 101708166 Publication Model: Electronic Cited Medium: Print ISSN: 2397-768X (Print) Linking ISSN: 2397768X NLM ISO Abbreviation: NPJ Precis Oncol Subsets: PubMed not MEDLINE

Binimetinib and encorafenib for the treatment of advanced solid tumors with non-V600E BRAF mutations: results from the Phase II BEAVER trial.

Authors: Rose AAN Maxwell J Rousselle E et al.

Source: Nature communications [Nat Commun] 2026 Jan 03; Vol. 17 (1), pp. 1323. Date of Electronic Publication: 2026 Jan 03.

Publication Type: Journal Article; Clinical Trial, Phase II

Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

Health-related quality of life outcomes from KEYNOTE-412: chemoradiotherapy with or without pembrolizumab in participants with head and neck squamous cell carcinoma.

Authors: Machiels JP Tao Y Licitra L et al.

Source: Frontiers in oncology [Front Oncol] 2025 Oct 06; Vol. 15, pp. 1645509. Date of Electronic Publication: 2025 Oct 06 (Print Publication: 2025).

Publication Type: Journal Article

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE

Longitudinal validation of ENLIGHT, an AI predictor of immunotherapy response and resistance, in pan-cancer cohorts.

Authors: Park CL Dinstag G Lopes CDH et al.

Source: NPJ precision oncology [NPJ Precis Oncol] 2026 Jun 15. Date of Electronic Publication: 2026 Jun 15.

Publication Type: Journal Article

Journal Info: Publisher: Springer Nature Country of Publication: England NLM ID: 101708166 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2397-768X (Print) Linking ISSN: 2397768X NLM ISO Abbreviation: NPJ Precis Oncol

CANLead: Canada as a Phase 1 Clinical Trial Leader - Opportunities, Initiatives, and Collaborative Innovation to Elevate National Competitiveness.

Authors: Adile AA Sran G Bedard PL et al.

Source: The oncologist [Oncologist] 2026 Jun 06; Vol. 31 (7).

Publication Type: Journal Article

Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print Cited Medium: Internet ISSN: 1549-490X (Electronic) Linking ISSN: 10837159 NLM ISO Abbreviation: Oncologist Subsets: MEDLINE

Methylation-based ctDNA monitoring in metastatic breast cancer during CDK4/6 inhibitor therapy.

Authors: Elliott MJ Fuentes-Antrás J Main SC et al.

Source: Nature communications [Nat Commun] 2026 Jun 04. Date of Electronic Publication: 2026 Jun 04.

Publication Type: Journal Article

Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

Longitudinal evaluation of serial ctDNA kinetics using joint modeling in patients with metastatic breast cancer.

Authors: Pretz C Fuentes-Antrás J Main S et al.

Source: NPJ precision oncology [NPJ Precis Oncol] 2026 Jun 03. Date of Electronic Publication: 2026 Jun 03.

Publication Type: Journal Article

Journal Info: Publisher: Springer Nature Country of Publication: England NLM ID: 101708166 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2397-768X (Print) Linking ISSN: 2397768X NLM ISO Abbreviation: NPJ Precis Oncol

Predicting immunotherapy benefit in leiomyosarcoma through active chromatin cfDNA profiling.

Authors: Lopes CDH Wu HT Dilger K et al.

Source: NPJ precision oncology [NPJ Precis Oncol] 2026 May 05. Date of Electronic Publication: 2026 May 05.

Publication Type: Journal Article

Journal Info: Publisher: Springer Nature Country of Publication: England NLM ID: 101708166 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2397-768X (Print) Linking ISSN: 2397768X NLM ISO Abbreviation: NPJ Precis Oncol

First-in-human study of the dual A2A/A2B adenosine receptor antagonist muvadenant (M1069) in patients with advanced solid tumors.

Authors: Siu LL Gutierrez ME Pudelko L et al.

Source: ESMO open [ESMO Open] 2026 May; Vol. 11 (5), pp. 106962. Date of Electronic Publication: 2026 May 07.

Publication Type: Journal Article; Clinical Trial, Phase I; Multicenter Study

Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 101690685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2059-7029 (Electronic) Linking ISSN: 20597029 NLM ISO Abbreviation: ESMO Open Subsets: MEDLINE

ESMO adaptation of Lines of Systemic Therapy (EnLiST): a consensus framework for standardising the designation of lines of therapy in solid tumours.

Authors: Saini KS Koopman M Martins-Branco D et al.

Source: Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2026 May; Vol. 37 (5), pp. 608-623. Date of Electronic Publication: 2026 Feb 17.

Publication Type: Journal Article; Consensus Statement; Practice Guideline

Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE

Pan-Cancer Pre-Treatment ctDNA Detection Using a Highly Sensitive Tumor-Informed Assay.

Authors: Strum S Murray C Genta S et al.

Source: International journal of molecular sciences [Int J Mol Sci] 2026 Apr 29; Vol. 27 (9). Date of Electronic Publication: 2026 Apr 29.

Publication Type: Journal Article

Journal Info: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067 (Electronic) Linking ISSN: 14220067 NLM ISO Abbreviation: Int J Mol Sci Subsets: MEDLINE

Hallmarks of Cancer: How did it inspire you?

Authors: Jae LT Siu LL Zhang L et al.

Source: Cell [Cell] 2026 Apr 16; Vol. 189 (8), pp. 2203-2205.

Publication Type: Journal Article

Journal Info: Publisher: Cell Press Country of Publication: United States NLM ID: 0413066 Publication Model: Print Cited Medium: Internet ISSN: 1097-4172 (Electronic) Linking ISSN: 00928674 NLM ISO Abbreviation: Cell Subsets: MEDLINE

Precision, Partnership, Purpose: Advancing Cancer Science to Save Lives Globally.

Authors: Siu LL; Princess Margaret Cancer Centre , University Health Network, University of Toronto, Toronto, Canada.

Source: Cancer discovery [Cancer Discov] 2026 Apr 01; Vol. 16 (4), pp. 629-632.

Publication Type: Journal Article

Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101561693 Publication Model: Print Cited Medium: Internet ISSN: 2159-8290 (Electronic) Linking ISSN: 21598274 NLM ISO Abbreviation: Cancer Discov Subsets: MEDLINE

Personalized ctDNA monitoring in metastatic HR+/HER2- breast cancer patients during endocrine and CDK4/6 inhibitor therapy.

Authors: Fuentes-Antrás J Elliott MJ Main SC et al.

Source: NPJ breast cancer [NPJ Breast Cancer] 2025 Jul 19; Vol. 11 (1), pp. 74. Date of Electronic Publication: 2025 Jul 19.

Publication Type: Journal Article

Journal Info: Publisher: Breast Cancer Research Foundation Country of Publication: United States NLM ID: 101674891 Publication Model: Electronic Cited Medium: Print ISSN: 2374-4677 (Print) Linking ISSN: 23744677 NLM ISO Abbreviation: NPJ Breast Cancer Subsets: PubMed not MEDLINE

Advances in cancer immunotherapy: adoptive cell therapy and immune cell engagers in solid tumours.

Authors: Panasci J Park CL Tran B et al.

Source: British journal of cancer [Br J Cancer] 2026 Jul; Vol. 135 (1), pp. 5-16. Date of Electronic Publication: 2026 Apr 27.

Publication Type: Journal Article; Review

Journal Info: Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1827 (Electronic) Linking ISSN: 00070920 NLM ISO Abbreviation: Br J Cancer Subsets: MEDLINE

First-in-human, phase 1 dose escalation study of SL-279252, a hexameric PD1-Fc-OX40L fusion protein, in patients with advanced solid tumors and lymphoma.

Authors: Johnson M Hong D Braña I et al.

Source: Investigational new drugs [Invest New Drugs] 2025 Apr; Vol. 43 (2), pp. 284-292. Date of Electronic Publication: 2025 Mar 05.

Publication Type: Journal Article; Clinical Trial, Phase I; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Springer Country of Publication: United States NLM ID: 8309330 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-0646 (Electronic) Linking ISSN: 01676997 NLM ISO Abbreviation: Invest New Drugs Subsets: MEDLINE

Investigating Early Kinetics in Plasma ctDNA and Peripheral T-cell Receptor Repertoire to Predict Treatment Outcomes to PD-1 Inhibitors in Head and Neck Squamous Cell Carcinoma.

Authors: Sanz-Garcia E Soleimani S Bruce JP et al.

Source: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2026 Feb 17; Vol. 32 (4), pp. 735-747.

Publication Type: Journal Article

Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE